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Abstract
Background: This study aimed to assess the predictive power of three different Sepsis Scoring Systems (SSSs),
namely maternity Systematic Inflammatory Response Syndrome (mSIRS), quick Sepsis-related Organ Failure
Assessment (qSOFA) and Modified Early Warning System (MEWS) in identifying sepsis by comparing them with
positive culture. This study also sought to evaluate compliance with using the Sepsis Six Care Bundle (SSCB)
operated in an individual health board.
Methods: A retrospective cohort study was conducted in 3 maternity hospitals of a single Scottish health board
that admitted 2690 pregnancies in a 12 weeks period in 2016. Data for study was obtained from medical notes,
handheld and electronic health records for women who were prescribed antibiotics with a confirmed or suspected
diagnosis of sepsis. Data on clinical parameters was used to classify women according to mSIRS, qSOFA and MEWS
as having sepsis or not and this was compared to results of positive culture to obtain sensitivity, specificity, positive
predictive value (PPV), negative predictive value (NPV) and area under Receiver Operating Characteristic curve
(AUROC) along with their 95% confidence intervals. Data was also obtained on SSCB compliance.
Results: A total of 89 women were diagnosed with sepsis, of which 14 had missing data, leaving 75 for final
analysis. Sensitivity, specificity, PPV, NPV and AUROC of mSIRS and MEWS were almost similar with AUROC of both
being around 50%. Only 33 (37.1%) had identifiable sepsis six sticker displayed on medical notes and only 2 (2.2%)
had all elements of SSCB delivered within the recommended one-hour post-diagnosis period. Blood culture and full
blood count with other lab tests had been performed for most women (97%) followed by intravenous antibiotics
and fluids (93.9%).
Conclusions: mSIRS and MEWS were quite similar in detecting sepsis when compared to positive culture, with
their ability to detect sepsis being close to chance. This underlines the need for creating a valid SSS with high
sensitivity and specificity for clinical use in obstetric settings. Clinical use of SSCB was limited despite it being a
health board policy, although there is considerable possibility of improvement following detailed audits and
removal of barriers for implementing SSCB.
Keywords: Sepsis, Sepsis scoring systems, Sepsis diagnosis, Obstetric, Maternity, Systemic inflammatory response
syndrome, SIRS, qSOFA, MEWS, Early warning systems, Sepsis six care bundle
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: nouf.a.abutheraa@strath.ac.uk
1Strathclyde Institute of Pharmacy and Biomedical Science in the University
of Strathclyde, Glasgow, UK
Full list of author information is available at the end of the article
Abutheraa et al. BMC Pregnancy and Childbirth          (2021) 21:524 
https://doi.org/10.1186/s12884-021-03921-3
Background
Sepsis was initially defined at the 1991 ACCP/SCCM
Consensus Conference as “a host’s systemic inflamma-
tory response syndrome (SIRS)” [1], based on a score ob-
tained using the patient’s temperature, heart rate (HR),
white cell count (WCC) and respiratory rate (RR) [1, 2].
In an obstetric population, changes associated with preg-
nancy and labour can make the SIRS baseline parame-
ters misleading for the identification of sepsis [3]. These
alterations in a woman’s normal physiology can mask
the initial phase of sepsis and delay diagnosis, hindering
appropriate clinical intervention and subsequent recov-
ery [4]. Interpretation of other biomarkers of infection
such as C-reactive protein (CRP) and WCC can also vary
with the mode of delivery that women experience [5, 6].
As a consequence, a number of alternate Sepsis Scoring
Systems (SSSs) were developed for maternity use such
Sepsis in Obstetric Score (SOS) [3] or others such as
maternity SIRS (mSIRS) [7] which are in use only in cer-
tain medical systems.
Not only for obstetric cases but even for the normal
population, a re-evaluation of the definition of sepsis
and SIRS after 24 years of clinical use found it to be defi-
cient in both specificity and sensitivity, as it failed to
capture many true cases of sepsis and identified infec-
tions that are not necessarily sepsis [1]. The re-
evaluation indicated that the SIRS construct, although
useful in identifying patients with infection, had limited
specific applicability to sepsis [1]. The definition of sep-
sis was overhauled during the 3rd International Consen-
sus Definition for Sepsis and Septic Shock [1]; the new
definition of sepsis being “life-threatening organ dys-
function caused by a dysregulated host response to an
infection” [1]. In order to detect sepsis in line with the
new definition, a Sepsis-related Organ Failure Assess-
ment (SOFA), and a quick SOFA (or qSOFA) were cre-
ated, comprising only three indices: mental status,
systolic blood pressure (SBP) and RR [1]; although SOFA
or qSOFA may not capable of replacing SIRS [2].
Apart from variations of SIRS, SOFA and qSOFA, the
Royal College of Obstetricians and Gynaecologists UK,
endorsed a pregnancy-specific scoring system, the Modi-
fied Obstetric Early Warning Score (MOEWS) [3, 8]
which was related to Modified Early Warning Score
(MEWS) for non-obstetric population [9]. A number of
MOEWS are in use in various facilities globally but very
few have been validated [9]. Evidence suggests that most
of these MOEWS are not as good when compared to
MEWS for obstetric use [9].
In addition to developing various SSSs for early detec-
tion of sepsis during obstetric care, it was also essential
to recognize that patients’ deterioration can be limited
by the early management of sepsis. This has led to the
application of care bundles as a mechanism for
minimizing harm and enhancing patient care [10]. The
Sepsis Six Care Bundle (SSCB) was recently introduced
into the maternity hospitals of the health region under
examination in this study, in the form of a sticker on pa-
tients’ notes, with the aim of delivering all six elements
of the bundle (Additional file 1: Sepsis Six Sticker)
within 1 h of sepsis being provisionally diagnosed. How-
ever, compliance has not been uniform and in line with
the suggestions of SSCB [11].
Thus, there are many variations of SSSs in obstetric
use across the world and very few have been validated
including some we were interested in. Hence, we
assessed mSIRS (since this was recommended by the
health board where this study was conducted), qSOFA
(an improvement over the earlier SIRS) and MEWS
(which performed better than all MOEWS [9]) in identi-
fying sepsis by applying these criteria to all pregnant
women treated for sepsis and by comparing them to
positive culture as a gold standard. In addition, we also
evaluated compliance with using the SSCB.
Methods
Study design and settings
A retrospective observational cohort study was con-
ducted within three maternity hospitals situated in a sin-
gle Scottish health region that admitted 2690 pregnant
women in a 12 weeks period in 2016. The study sample
comprised all women admitted to these maternity hospi-
tals during the study period who received antibiotic
therapy for a suspected or confirmed diagnosis of sepsis.
Data collection and subject identification
Patients were identified through hospital handover
sheets or/and drug Kardexes® (records of patients’ medi-
cation prescription and administration). Women ≤16
years of age were excluded. Women were also excluded
if antibiotics were prescribed prophylactically; such
women were included only if they required additional
treatment following a diagnosis of sepsis.
Individual demographic characteristics including pa-
tient’s age, body mass index (BMI), gestational age,
mode of delivery and unit of hospitalization were col-
lected. Data on each patient’s temperature, heart rate
(HR), respiratory rate (RR), systolic blood pressure (SBP)
and mental status were collected from individual
MOEWS charts, while individual data on WCC and
microbiology reports (positive culture) were collected
from patient electronic health records (EHRs).
Patient’s clinical notes were then reviewed to deter-
mine whether the SSCB had been commenced and used
appropriately. This evaluation was not reported for pa-
tients who were commenced on the bundle without the
use of the SSCB sticker.
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Data management
Based on the various SSSs that were evaluated, the
values of all required patient parameters such as HR,
RR, SBP, mental status etc. were dichotomized to be
normal or abnormal. These dichotomized values were
then combined to create a composite score for a particu-
lar SSS to evaluate whether a patient had sepsis or not
based on a particular SSS. Positive culture results were
used to evaluate the selected SSSs.
Data analysis
All analysis was performed using SPSS Statistics for
Windows, Version 23.0 (Armonk, NY: IBM Corp.).
Means, standard deviations and range was calculated for
all continuous variables. Counts and percentages were
calculated for all categorical variables. We evaluated
three SSSs – mSIRS, qSOFA and MEWS (we selected
MEWS and not any of the MOEWS since a recent study
discovered MOEWS to be less effective than MEWS in
detecting sepsis early in obstetric settings [9]) with posi-
tive culture results as gold standard to obtain sensitivity,
specificity, positive predictive value (PPV) and negative
predictive value (NPV) along with their 95% confidence
intervals (CIs). To summarize our evaluation of SSSs we
calculated Receiver Operating Characteristic (ROC)
curve along with area under the ROC (AUROC) and
95% CIs. We also assessed compliance with the SSCB in
our study by calculating the counts and percentages of
patients receiving the six elements of SSCB.
Results
This study included a total of 89 (3.3%) women, diag-
nosed with sepsis, from a total of 2690 pregnancies, in a
single health region in Scotland during a 12-week study
period in 2016.
Table 1 summarises the demographic details of the 89
women based on the data available in the EHRs. The
average age of these women was 29.8 (± 5.3) years and
ranged from 19 to 45 years. A total of 19 (24.7%) women
were classified as obese with Body Mass Index (BMI)
equal to or greater than 30, with most women (46.7%)
having a normal BMI. Most women (94%) were in the
third trimester, with the greatest proportion of deliveries
occurring via emergency caesarean section (46.1%),
followed by spontaneous vaginal delivery (24.7%). The
majority of women (89.9%) were admitted either into the
antenatal or postnatal wards with very few in high de-
pendency unit (7.9%) or intensive care unit (2.2%).
Data for evaluating Sepsis Scoring Systems (SSSs) was
available only for 75 out of 89 (84.3%) women. Various
Sepsis Scoring Systems, namely mSIRS, qSOFA and
MEWS (Table 2), were compared with positive culture
(Table 3), to obtain characteristics such as sensitivity,
specificity, PPV, NPV and AUROC. mSIRS and MEWS
were found to be comparable with regards to most char-
acteristics – sensitivity [mSIRS: 0.655 (95% CI – 0.643-
0.668); MEWS: 0.690 (95% CI – 0.678-0.702)], specificity
[mSIRS: 0.391 (95% CI – 0.379-0.404); MEWS: 0.304
(95% CI – 0.292-0.316)], PPV [mSIRS: 0.404 (95% CI –
0.391-0.417); MEWS: 0.385 (95% CI – 0.372-0.397)], and
NPV [mSIRS: 0.643 (95% CI – 0.630-0.655); MEWS:
0.609 (95% CI – 0.596-0.621)]. AUROC for both were
close to 50% (mSIRS AUROC – 0.524 (95% CI - 0.388-
0.659) and MEWS AUROC – 0.497 (95% CI - 0.354-
0.639). Thus, specificity, PPV, NPV and AUROC were
slightly higher for mSIRS compared to MEWS. qSOFA
on the other hand was positive (score ≥ 2) for only 2
women both of whom had negative cultures (Table 3).
We also evaluated the use of Sepsis Six Care Bundle
(SSCB) for 33 (37.1%) women (Table 4), who had the
sepsis six sticker on their medical notes, and discovered
that most women received 5 of the 6 elements of SSCB.
Most women had blood culture, and full blood count
with other lab tests performed (97%) followed by intra-
venous antibiotics and intravenous fluids (93.9%).
Catheterization was done for 78.8% women and 27.3%
women administered oxygen. It is important to note
here that only 2 cases received all 6 elements of SSCB
Table 1 Demographic information of pregnant women (N = 89)
diagnosed with suspected sepsis in maternity wards of 3
hospitals of a health board in Scotland
Demographic variables Values (N = 89)
Age
Mean ± SD (Min-Max) 29.8 ± 5.3 (19–45)
BMI (kg/m2)a
Normal (18.5–24.9) 36 (46.7%)
Overweight (25–30) 22 (28.6%)
Obese (≥ 30) 19 (24.7%)
Gestational ageb
First trimester 0
Second trimester 5 (6%)
Third trimester 79 (94%)
Delivery modec – n (%)
Emergency caesarean section 41 (46.1%)
Spontaneous vaginal delivery 22 (24.7)
Instrumental delivery 14 (15.7%)
Eelective caesarean section 1 (1.1%)
Unit of hospital admission – n (%)
Antenatal or Postnatal ward 80 (89.9)
High Dependency Unit 7 (7.9)
Intensive Care Unit 2 (2.2)
aData were missing for 12 women; bData were missing for 5 women; cData
were missing for 11 women, of whom 7 were diagnosed with sepsis in the
antenatal period
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within the prescribed 1 h of being diagnosed with sepsis
– at 35 and 40min from time zero.
Discussion
Our study on 89 women, in a single health board in
Scotland, which compared three different SSSs – namely
mSIRS, qSOFA and MEWS, with positive culture, re-
vealed comparable performance by mSIRS and MEWS
with similar values for sensitivity, specificity, PPV, NPV
and AUROC. Most importantly the values for AUROC
for both mSIRS and MEWS were around 50% indicating
that their ability to predict sepsis was close to chance
compared to positive culture. Estimates for qSOFA were
unreliable in our study due to low number of women
with positive qSOFA.
On evaluating compliance with the use of SSCB, only
33 (37.1%) of these women were found to have sepsis six
sticker on their medical notes denoting low levels of
compliance with providing timely recommended sepsis
care. Among those who received SSCB, only 2 women
received it within the recommended 1 h following diag-
nosis. While most received 4/6 elements of SSCB, only
around 79% received catheterization and the minority
(27.3%) were administered oxygen.
Our findings regarding comparison of SSSs with posi-
tive culture threw up meaningful results only for mSIRS
and MEWS. mSIRS is a modification of the SIRS criteria
and has been in use in the hospitals of the health board
since 2015 [7]. mSIRS performance was similar to that
of MEWS which indicated that mSIRS was probably one
of the better performing SSS in obstetric settings. This
can be inferred in the light of findings where MEWS
was compared to six different published MOEWS and
was found to perform better than all of them [9]. The
different MOEWS were reported to have low PPV, ran-
ging between 1.4 and 5.1%, while AUROC ranged from
0.52 to 0.72 [9].
The use of SIRS criteria in the original definition of
sepsis were not specific and its values can be elevated in
cases of other non-infectious disease such as burns or
injury and in cases unrelated to infection [12, 13]. In
addition, women undergo changes in their physiological
and laboratory measurements during pregnancy and
post-partum periods. These changes overlapped with the
SIRS criteria and made the diagnosis critical, particularly
when respiratory rate, heart rate, white cell count and
blood pressure values, expected to be outside the adult
normal reference range [12, 13].
An important thing to note here is the continued use
of mSIRS (though SIRS was found highly inadequate
after decades of use [1]) in the health board that was
studied and the presence of numerous MOEWS in vari-
ous obstetric setting across the world; this points to-
wards the lack of consensus [13] about a single validated
SSS which is needed for use in obstetric settings and is
currently missing.
Table 3 Comparison of Sepsis Scoring Systems against Positive Culturea for pregnant women (N = 75) diagnosed with probable
sepsis in maternity wards of 3 hospitals of a health board in Scotland
Characteristics Sepsis Scoring Systems for Maternity Care
% (95%CI)b
Maternity SIRS qSOFAc MEWS
Sensitivity 0.655 (0.643–0.668) 0 0.690 (0.678–0.702)
Specificity 0.391 (0.379–0.404) 0.957 (0.951–0.962) 0.304 (0.292–0.316)
PPV 0.404 (0.391–0.417) 0 0.385 (0.372–0.397)
NPV 0.643 (0.630–0.655) 0.603 (0.589–0.603) 0.609 (0.596–0.621)
AUROC 0.524 (0.388–0.659) 0.301 (0.045–0.558) 0.497 (0.354–0.639)
a29 patients had a positive culture; b CI Confidence Interval; cOnly 2 patients had qSOFA score of 2 and both had negative cultures
Table 2 Comparison chart of Sepsis Scoring Systems useful for maternity care for pregnant women diagnosed with probable sepsis
in maternity wards of 3 hospitals of a health board in Scotland
Parameters or Criteria used
in Sepsis Scoring Systems
Sepsis Scoring Systems Analysed in the Current Studya
SIRSa Maternity SIRS qSOFA MEWS
Temperature (°C) < 36 or > 38 < 36 or > 38 – ≤ 36 or > 38
Heart rate (bpm) > 90 > 100 – ≤ 50 or > 110
White cell count < 4 or > 12 × 109/L < 4 or > 16 × 109/L –
Respiratory rate (bpm) > 20 > 20 ≥ 22 < 9 or > 14
Systolic blood pressure (mmHg) – < 90 ≤ 100 ≤ 100 or > 199
Mental status – Altered mental status Altered mental status Altered mental status
aAll except SIRS were compared in the study. SIRS has been made a part of the table to show its differences with Maternity SIRS
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It has been proposed that the qSOFA definition should
be able to identify women at an early stage of severe ma-
ternal infection to allow healthcare practitioners to initi-
ate treatment [14]. The definition of severe maternal
sepsis excludes the early stage of sepsis and delays the
initiation of treatment for these women. The new defin-
ition of maternal sepsis is “a life-threatening condition
defined as organ dysfunction resulting from infection
during pregnancy, childbirth, post-abortion, or the post-
partum period” [15]. When applied to our sample, this
criterion was able to determine sepsis in only two
women. It seems that it can be used in very sick women
to determine their need for ICU admission, but has lim-
ited applicability to sepsis cases in maternity wards.
Finally, we considered comparing the various SSSs to
positive culture. Our results with different SSSs show
uncertainty about systems to be used in diagnosis and
culture-proven sepsis is still the diagnostic gold stand-
ard. There were only 29 positive culture results among
75 women (38.6%), which is in line with the evidence
[16]. Despite being the gold standard there are severe
deficiencies in using culture tests in clinical settings due
to poor specificity and precious time lost in waiting for
culture results [16]. These shortcomings with cul-
ture tests further underline the need for creating an ef-
fective SSS with high sensitivity and specificity for early
use in clinical settings.
The early identification and management of sepsis in
maternity is recommended [17], as delay in diagnosis or
treatment can lead to maternal mortality and morbidity,
which are associated with a delay in administering the
appropriate therapy and management to these women
[18]. Culture-proven sepsis results were obtained 48 h
after therapy had been initiated for these women, and an
early identification tool is necessary so that treatment
can be delivered early. The limited applicability of vari-
ous biomarkers due to the non-specific or non-sensitive
nature of these criteria, arising from the altered
physiological functions of pregnant women, could lead
to under- or over-treatment. The unnecessary use of
antibiotic therapy to treat maternal sepsis could drive
antibiotic resistance and further medical complications
[4, 19], while delay in managing sepsis can result in
many complications including organ failure, hysterec-
tomy and death [18–20].
The use of clinical judgement is currently recom-
mended to facilitate the diagnosis of sepsis, which
should not rely solely on SSSs or laboratory tests [20].
Chorioamnionitis cases, for example, may have a clinical
diagnosis and a histological diagnosis but women might
not have a positive microbiological culture while being
treated with antibiotic for clinical chorioamnionitis [20].
Overall, the current system of diagnosing sepsis hardly
relies on the effectiveness of the early warning scores
and this might be a hindrance for validating these tools
in identifying ill patients.
In order to make SSSs more effective, addition of
biomarkers has been suggested. Procalcitonin (PCT)
shows better prediction of sepsis compared to CRP;
nevertheless, there is a reported lack of accuracy
[21]. Serum PCT rises and peaks in a short time
compared to CRP and it has been found to be useful
in modern clinical practice. However, there is limited
information about PCT in pregnancy, and determin-
ing the most appropriate reference range of this bio-
marker in pregnant women [22]. Its high level of
negative predicted values leads to a misleading iden-
tification of sepsis [23]. Martín and colleagues rec-
ommend the design of a scoring system based on
combined biomarker values including CRP, PCT and
lactate to aid physicians in their treatment decisions,
which has the potential to reduce the use of antibi-
otics and of culture tests [24].
With respect to compliance with SSCB, recent stud-
ies have indicated that very few patients received all
the six interventions of the bundle within the recom-
mended 1 h and the elements were not consistently
applied [11]. This is in line with our findings. There
are possibly a number of barriers that might hinder
the timely and effective delivery of SSCB – a few
have been described such as insufficient audit and
feedback, poor teamwork and communication, inad-
equate training, lack of resources and concerns about
using SSCB in certain patients [25]. However, health
personnel also displayed positive factors in favour of
SSCB such as confidence in knowledge and skills, and
belief in the benefits of SSCB among others [25].
Since compliance with SSCB can vary among facil-
ities, regular audits, continued use, further research
into non-compliance at facility level and improving
the strengths of the staff at facility level can lead to
better implementation of SSCB.
Table 4 Details of compliance with each element of the Sepsis
Six Care Bundle (SSCB) for pregnant women (N = 33) diagnosed
with probable sepsis in maternity wards of 3 hospitals of a
health board in Scotland
Care/therapy Compliance with the
care at any time point
n (%)
Oxygen 9 (27.3%)
Blood culture 32 (97%)
Full blood count and other lab tests 32 (97%)
Intravenous antibiotics 31 (93.9%)
Intravenous fluid 31 (93.9%)
Catheter 26 (78.8%)
Note: Only for 2 cases SSCB was delivered within the prescribed one-hour
period - reported times being 35 and 40 min from time zero
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Conclusions
In conclusion, access to a large database from maternity
hospitals of a health board provided appreciable data on
pregnant women with sepsis. Overall, the study indicated
that mSIRS and MEWS were quite similar and weak in
their characteristics in detecting sepsis in obstetric set-
tings when compared to positive culture as a gold stand-
ard. Also, compliance with SSCB was low and
administering care for all 6 elements in SSCB was not
uniform. This study highlights the need for a rapid,
point of care technology, incorporating a panel bio-
marker of greater specificity/sensitivity to support a SSS
with superior prediction powers than currently available
tools.
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